Absence of activating mutations in the hot spots of the LH receptor and Gs-α genes in Leydig cell tumors

Journal of Endocrinological Investigation

Volumn 25, Issue 7, 2002, Pages 598-602

  Vieira, T C A ^a   Cerutti, J M ^a   Dias da Silva, M R ^a   Delcelo, R ^a   Abucham, J ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Activating mutations; Gs alpha gene; Leydig cell tumor; LH receptor gene; Precocious puberty; Virilization

Indexed keywords

CYCLIC AMP; DNA; G PROTEIN COUPLED RECEPTOR; LUTEINIZING HORMONE RECEPTOR; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA; THYROID HORMONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; DNA EXTRACTION; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; HORMONE DETERMINATION; HUMAN; HUMAN CELL; HYPERANDROGENISM; LEYDIG CELL TUMOR; LYMPHOCYTE; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRECOCIOUS PUBERTY; PRESCHOOL CHILD; SIGNAL TRANSDUCTION; VIRILIZATION;

AGED; AGED, 80 AND OVER; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; LEYDIG CELL TUMOR; MALE; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, LH; SEQUENCE ANALYSIS, DNA; TESTICULAR NEOPLASMS;

EID: 0036067054     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345082     Document Type: Article

References (42)

1. Cloning and sequencing of human LH/hCG receptor cDNA
2. Clinical manifestations of genetic defects affecting gonadotropins and their receptors
3. A constitutively activating mutation of the luteinizing hormone receptor in familial male-limited precocious puberty
4. A sporadic case of Male-limited precocious puberty has the same constitutively activating point mutation in LH/hCG receptor gene as familial cases
5. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor (hLHR) in familial male-limited precocious puberty
6. A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty
7. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty
8. Severe testotoxicosis phenotype associated with Asp578Tyr mutation of the lutrophin/choriogonadotrophin receptor gene
9. A mutation in the first transmembrane domain of the LHR causes male precocious puberty
10. A unique constitutively activating mutation in the third transmembrane helix of the LHT causes sporadic male gonadotropin-independent precocious puberty
11. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function
12. Legdig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor
13. The expanding spectrum of G protein diseases
14. Abnormalities in G protein-coupled signal transduction pathways in human disease
15. Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors
16. G protein abnormalities in pituitary adenomas
17. Gsα and Gi2a mutations in clinically non-functioning pituitary rumors
18. Activating mutations of the stimulatory G protein in the McCune Albright syndrome
19. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as cause of toxic thyroid adenomas
20. Rapid GDP release from Gsα in patients with gain and loss of endocrine function
21. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors
22. Analysis of mutations in genes of the follicle-stimulating hormone receptor-signaling pathway in ovarian granulosa cell tumors
23. Mutation analysis of gonadotropin receptor and G protein genes in various types of human ovarian tumors
24. Two G protein oncogene in human endocrine tumors
25. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors
26. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors
27. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors
28. GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumors
29. Rare mutations of the Gs alpha subunit gene in human endocrine tumors
30. Analysis of the GS-alpha gene in growth hormone-secreting pituitary adenomas by PCR direct sequencing method using paraphin-embedded tissues
31. Diversity and prevalence of somatic mutations in the TSH receptor and GS-alpha genes as a cause of toxic thyroid adenomas
32. Activating mutations of TSH receptor: A short review with emphasis on some pediatric aspects
33. Toxic thyroid adenoma: Absence of DNA mutations of the TSH receptor and Gs-alpha
34. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms
35. Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil
36. Rarity of oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in Japan
37. Somatic mutations in the TSH receptor gene and not in the Gs-alpha protein gene in 31 toxic thyroid adenomas
38. Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: Implications for tumorigenesis
39. Mutations in adrenocortical tumors
40. Activating mutations of the gsp oncogene in human thyroid adenomas
41. Gs-alpha and Gi2-alpha mutations in clinically nonfunctioning pituitary tumors
42. G protein abnormalities in pituitary adenomas